Study Results Available on Dexpramipexole for Eosinophilic Asthma
source: shutterstock.com

Study Results Available on Dexpramipexole for Eosinophilic Asthma

  The Phase 2 EXHALE-1 clinical trial, initiated by clinical-stage biotechnology company Areteia Therapeutics, Inc. ("Areteia"), sought to understand how safe, effective, and well-tolerated dexpramipexole was in reducing symptoms of…

Continue Reading Study Results Available on Dexpramipexole for Eosinophilic Asthma